GP和NP方案治疗晚期非小细胞肺癌的疗效观察

在我国,肺癌已占大城市癌症发病率和死亡率的首位,而且预后极差。20世纪80年代时,用顺铂(cisplatin,DDP)联合丝裂霉素和长春地辛组成标准的化疗方案治疗非小细胞肺癌(non-small cell lung cancer,NSCLC),其中位生存期仅4~5月,1年生存率为10%~15%。90年代时,随着长春瑞宾、紫杉醇、多西紫杉醇、吉西他滨、伊立替康等新一代抗肿瘤药与铂类联合化疗的应用,将晚期NSCLC患者中位生存期提高到9~10个月,1年生存率提高到30%~50%。我院自2001年1月至2003年12月应用吉西他滨(健泽,gemcitabine)联合顺铂(GP)和长春瑞宾(盖诺,...

Full description

Saved in:
Bibliographic Details
Published inZhongguo fei ai za zhi Vol. 9; no. 4; pp. 379 - 380
Main Author 李思维 李拥军 胡远强 蔡正斌
Format Journal Article
LanguageChinese
Published Tianjin Chinese Anti-Cancer Association Chinese Antituberculosis Association 01.07.2006
443000,宜昌市第二人民医院放化疗科
Subjects
Online AccessGet full text
ISSN1009-3419
1999-6187
DOI10.3779/cjlc.v9i4.2278

Cover

Abstract 在我国,肺癌已占大城市癌症发病率和死亡率的首位,而且预后极差。20世纪80年代时,用顺铂(cisplatin,DDP)联合丝裂霉素和长春地辛组成标准的化疗方案治疗非小细胞肺癌(non-small cell lung cancer,NSCLC),其中位生存期仅4~5月,1年生存率为10%~15%。90年代时,随着长春瑞宾、紫杉醇、多西紫杉醇、吉西他滨、伊立替康等新一代抗肿瘤药与铂类联合化疗的应用,将晚期NSCLC患者中位生存期提高到9~10个月,1年生存率提高到30%~50%。我院自2001年1月至2003年12月应用吉西他滨(健泽,gemcitabine)联合顺铂(GP)和长春瑞宾(盖诺,
AbstractList 在我国,肺癌已占大城市癌症发病率和死亡率的首位,而且预后极差。20世纪80年代时,用顺铂(cisplatin,DDP)联合丝裂霉素和长春地辛组成标准的化疗方案治疗非小细胞肺癌(non-small cell lung cancer,NSCLC),其中位生存期仅4~5月,1年生存率为10%~15%。90年代时,随着长春瑞宾、紫杉醇、多西紫杉醇、吉西他滨、伊立替康等新一代抗肿瘤药与铂类联合化疗的应用,将晚期NSCLC患者中位生存期提高到9~10个月,1年生存率提高到30%~50%。我院自2001年1月至2003年12月应用吉西他滨(健泽,gemcitabine)联合顺铂(GP)和长春瑞宾(盖诺,
R73
Author 李思维 李拥军 胡远强 蔡正斌
AuthorAffiliation 宜昌市第二人民医院放化疗科,443000
AuthorAffiliation_xml – name: 443000,宜昌市第二人民医院放化疗科
Author_xml – sequence: 1
  fullname: 李思维 李拥军 胡远强 蔡正斌
BookMark eNpFz0FLAkEUB_AhDFLr2geoQ6e1mbezMzvdQtICKQ_eZXZ3xjTZTTcLPFqEByEIMpRSOnUsupWfx137Fm0YdPo_eD_-j5dBKT_wFUKbBOdMzsWu22i6uUtRpzkAbq-gNBFCGIzYPJXMGAvDpESsoUwYNjBmIEyaRnvF8vx-cFyOhp_RSz_6mMXDx2g0jp6m38-T-ftdPLtdXE8Wva94NIjHN7_bh_7itTd_m66jVS2bodr4yyyqFA4q-UOjdFI8yu-XDNfmwvA8l4K2OOGYC6k0AcfSJhAMPAmmHErBUppywGA5DsUO4-CB9IhUXElmZtHOsvZK-lr6tWoj6LT95GC1W9Oy24XkF0wxEYncXsrzdtDqqPDinwIBzmwqmJmoraVyTwO_1qonjY50z3S9qaoAFgVOmfkDAw51CQ
ClassificationCodes R73
ContentType Journal Article
Copyright Copyright © 2006. This work is published under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: Copyright © 2006. This work is published under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 2RA
92L
CQIGP
W91
~WA
ABUWG
AFKRA
AZQEC
BENPR
BVBZV
CCPQU
DWQXO
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
2B.
4A8
92I
93N
PSX
TCJ
DOI 10.3779/cjlc.v9i4.2278
DatabaseName 维普期刊资源整合服务平台
中文科技期刊数据库-CALIS站点
中文科技期刊数据库-7.0平台
中文科技期刊数据库-医药卫生
中文科技期刊数据库- 镜像站点
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
ProQuest Central
ProQuest East & South Asia Database
ProQuest One Community College
ProQuest Central
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitle Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Central China
East & South Asia Database
ProQuest Central
ProQuest One Academic UKI Edition
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
DatabaseTitleList

Database_xml – sequence: 1
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1999-6187
EndPage 380
ExternalDocumentID zgfazz200604019
22542746
GroupedDBID ---
-05
04C
29R
2B.
2C~
2RA
2WC
3V.
5GY
5VS
6PF
92F
92I
92L
AAWTL
ABUWG
ACGFS
AFKRA
ALMA_UNASSIGNED_HOLDINGS
BENPR
BPHCQ
BVBZV
C1A
CCEZO
CDYEO
CIEJG
CQIGP
CW9
CXBCV
DIK
E3Z
EBD
EIHBH
EMOBN
EOJEC
F5P
GROUPED_DOAJ
HYE
IPNFZ
KQ8
KWQ
OBODZ
OK1
PIMPY
PQEST
PQQKQ
PQUKI
PROAC
RIG
RNS
RPM
TCJ
TGQ
U1G
U5O
W91
~WA
AZQEC
CCPQU
DWQXO
OVT
PGMZT
PHGZM
PHGZT
PKEHL
PRINS
4A8
93N
PMFND
PSX
ID FETCH-LOGICAL-c879-ddc42f5717079aef12b5f321027f326eb4425ef472025bb40b672d2ad1ae7ea63
IEDL.DBID BENPR
ISSN 1009-3419
IngestDate Thu May 29 03:56:16 EDT 2025
Sun Jun 29 15:35:52 EDT 2025
Thu Nov 24 20:30:11 EST 2022
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Language Chinese
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c879-ddc42f5717079aef12b5f321027f326eb4425ef472025bb40b672d2ad1ae7ea63
Notes R521
R734.2
12-1395/R
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
OpenAccessLink https://www.proquest.com/docview/2127684963?pq-origsite=%requestingapplication%
PQID 2127684963
PQPubID 2055412
PageCount 2
ParticipantIDs wanfang_journals_zgfazz200604019
proquest_journals_2127684963
chongqing_backfile_22542746
PublicationCentury 2000
PublicationDate 20060701
PublicationDateYYYYMMDD 2006-07-01
PublicationDate_xml – month: 07
  year: 2006
  text: 20060701
  day: 01
PublicationDecade 2000
PublicationPlace Tianjin
PublicationPlace_xml – name: Tianjin
PublicationTitle Zhongguo fei ai za zhi
PublicationTitleAlternate Chinese Journal of Lung Cancer
PublicationTitle_FL CHINESE JOURNAL OF LUNG CANCER
PublicationYear 2006
Publisher Chinese Anti-Cancer Association Chinese Antituberculosis Association
443000,宜昌市第二人民医院放化疗科
Publisher_xml – name: Chinese Anti-Cancer Association Chinese Antituberculosis Association
– name: 443000,宜昌市第二人民医院放化疗科
SSID ssj0062934
ssib002262905
ssib001103766
ssib038074678
ssib044765436
ssib051369142
Score 1.6988766
Snippet 在我国,肺癌已占大城市癌症发病率和死亡率的首位,而且预后极差。20世纪80年代时,用顺铂(cisplatin,DDP)联合丝裂霉素和长春地辛组成标准的化疗方案治疗非小细胞肺癌(non-small cell lung...
R73
SourceID wanfang
proquest
chongqing
SourceType Aggregation Database
Publisher
StartPage 379
SubjectTerms cancer
GP
NP
中位生存期
多西紫杉醇
方案治疗
晚期非小细胞肺癌
疗效观察
联合化疗
长春瑞宾
Title GP和NP方案治疗晚期非小细胞肺癌的疗效观察
URI http://lib.cqvip.com/qk/91098A/20064/22542746.html
https://www.proquest.com/docview/2127684963
https://d.wanfangdata.com.cn/periodical/zgfazz200604019
Volume 9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3PTxNBFJ5oiYaLUZRYQdOD1wVm9u1Ml4tBAxITmsZAwq2ZmZ0tqNmCVEl6BEI4kJiYiIEoxJNHjTfl7-m2_Be8R4cWL5z28Hb28PbN937N-4axp6Gl3lqSBspqGYAJTWBUxIPQgYUw4cAveGYXKnJ-CV4tR8u-4Lbhj1VeYuIFUCcNSzXySWIil2VAe3m2th7QrVHUXfVXaNxkQygvo50PPZ-tVF8PAgIag7uaoAgp4oGFE9s6IkXfAgEUzVr23494KGMOfUIqXNzrU1NLgZjQejSQRNo3ad-8sxMf41WYoOlSompYaWT1dXRA_wWvtzZ1luqsfsWLzd1ld3z4WZrp2cs9dqO1MsJuL_gG-302_bLa_rxfqeYHf_Mfe_mf087B1_zwKP92cvb9uP37U-d0t7t93N361znc7xztkPTLXvfnVvvXyQO2ODe7-GI-8NcrBLas4iBJLIg0wnRuSsXapVyYKKWJHqHwIZ0B3M4uBSUwLDIGpoxUIhE64dopp2U4ygpZI3MPWSkWDiLnXEjk9tYZEyNqlg06f60UB11kY31loHe2b4lzqoZIApgTyyIbv1RPzW-gjdrgdxdZyatsIG3VU91qUTUEMYjHj67_whgb7hVO6JDtOCs0339wjzGUaJon3l7OAXFA0GE
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VVDwuiKcILZADHN3W6_FujIQQj5aUNlGEgtSbtbtepzzkUFqoyLEg1EMlJCSKWkErTpwQiBv098QJ_4Kd2knKhVtPPqy9h_G3s9_M7HwLcNXTVFuLYkdoyR1UnnKU8F3HM6jRi1x093VmqzVeeYj3F_yFEfjW74WhY5V9n7jvqKOWphz5JCmR8zJavNx8tuTQrVFUXe1foZHBYs68WrUh2_KN2bv2_15jbGa6cafi5LcKOLosAieKNLLYt1HMlAikiV2m_JgaWZiwD24UWhSbGAWzbEApnFJcsIjJyJVGGMk9O-0RGEVqaC3A6O3pWv3BkH9Q193BeIhxFgwXFIm7W8c0ADyioNbOwfu-6_HAxYH-lf04K4tTBYOE1zLVSdIInNSPn-qJl8EjnKBmVlKGWGwlzSW73_3DlY-uyiSWSfPApjlzCk7mbLd0K4PnaRhpL56BY9W8nn8Wrt-rd95v1Orp5q_0y3r6c6-7-THd2k4_7f75vNP58a6797b3eqe39ru7tdHdfkOjH9Z7X9c633fPQeMw7H4eCkkrMRegFDCDvjHGIy19bZQKrJMuK8s1pBAuyiKMDYxhyYB-QhJXoXVcaENwXoTxvnnCfL0uh0N0FaGUm2w42m7Gst2m5It1eW5w8f8zXIHjlUZ1Ppyfrc2NwYksZ0Pne8ehsPL8hblkWcyKupxjpwThIaP1L8YCDBs
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3PT9RAFH7BJRIu_jauoO5Bj92l02mnNTFGxBVENntAQrw0M9PpgpiuyCKxRzSGA4mJiRiIQjx51HhD_hPv213_C-fRdhc9eOPgqYdpm6bfmzffzHvvewDXLYmxtSA0mOSOQYUlDMFs07AUldQKTGoe6szO1JzJR_TBvD0_APt5LQymVeY-8dBRB02JZ-QVVCJ3XKrtpRJmaRH1iertZ8sGdpDCSGveTiM1kWn1ck1v31ZuTU1orG8QUr03e3fSyDoMGNJlnhEEkpLQ1juaMeZxFZpE2CEWtRCmL44SVFu0CikjmhkIQceEw0hAeGByxRR3LP3aEzDoOq5NCjA4Pjf-eK7PRbAC7-jeiDjE608uFHrXTqpn_JQyLPPs3W-bluOZtKeFpR9OQ-QYzUARtlSBEvUCK_LJU1l-4S3SMha2okrEQjNqLOu17w_efHKNRyGPGkcW0Opp-Jn_-jRvZqm82hJlGf-lSvlfYnMGTmW0vnQnnYdnYSBeOAdDM1niwnm4eb_efrdZqydb-8nnjeT7QWfrQ7K9k3zc-_Vpt_3tbefgTffVbnf9R2d7s7PzGkffb3S_rLe_7l2A2eP48ItQiJqRugQljyhqK6UsbBoglRCeXo1coUkVZ8ykvAgjPaQ165FLqOXlaw9NibatIozmaPmZY1rx-1AVoZTZQ380boQ8jvGUSft207v87zdcgyENs_9wqjY9AsPp2RTmMY9CofV8VV3RbK0lrmbzogT-MaP9Gx5KV1o
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=GP%E5%92%8CNP%E6%96%B9%E6%A1%88%E6%B2%BB%E7%96%97%E6%99%9A%E6%9C%9F%E9%9D%9E%E5%B0%8F%E7%BB%86%E8%83%9E%E8%82%BA%E7%99%8C%E7%9A%84%E7%96%97%E6%95%88%E8%A7%82%E5%AF%9F&rft.jtitle=%E4%B8%AD%E5%9B%BD%E8%82%BA%E7%99%8C%E6%9D%82%E5%BF%97&rft.au=%E6%9D%8E%E6%80%9D%E7%BB%B4&rft.au=%E6%9D%8E%E6%8B%A5%E5%86%9B&rft.au=%E8%83%A1%E8%BF%9C%E5%BC%BA&rft.au=%E8%94%A1%E6%AD%A3%E6%96%8C&rft.date=2006-07-01&rft.pub=443000%2C%E5%AE%9C%E6%98%8C%E5%B8%82%E7%AC%AC%E4%BA%8C%E4%BA%BA%E6%B0%91%E5%8C%BB%E9%99%A2%E6%94%BE%E5%8C%96%E7%96%97%E7%A7%91&rft.issn=1009-3419&rft.volume=9&rft.issue=4&rft.spage=379&rft.epage=380&rft_id=info:doi/10.3779%2Fcjlc.v9i4.2278&rft.externalDocID=zgfazz200604019
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F91098A%2F91098A.jpg
http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fzgfazz%2Fzgfazz.jpg